Sisram Medical
Market Cap
HK$2.2b
Last Updated
2021/01/24 10:21 UTC
Data Sources
Company Financials
Executive Summary
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical and minimally invasive treatment systems in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. More Details
Snowflake Analysis
Flawless balance sheet and slightly overvalued.
Similar Companies
Share Price & News
How has Sisram Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1696 is more volatile than 90% of Hong Kong stocks over the past 3 months, typically moving +/- 17% a week.
Volatility Over Time: 1696's weekly volatility has increased from 10% to 17% over the past year.
Market Performance
7 Day Return
66.0%
1696
11.2%
HK Medical Equipment
3.6%
HK Market
1 Year Return
22.0%
1696
115.1%
HK Medical Equipment
15.8%
HK Market
Return vs Industry: 1696 underperformed the Hong Kong Medical Equipment industry which returned 115.1% over the past year.
Return vs Market: 1696 exceeded the Hong Kong Market which returned 15.8% over the past year.
Shareholder returns
| 1696 | Industry | Market | |
|---|---|---|---|
| 7 Day | 66.0% | 11.2% | 3.6% |
| 30 Day | 47.2% | 14.6% | 12.7% |
| 90 Day | 101.2% | 21.5% | 18.3% |
| 1 Year | 27.4%22.0% | 118.5%115.1% | 20.4%15.8% |
| 3 Year | -23.7%-28.8% | 221.3%206.1% | -4.5%-14.6% |
| 5 Year | n/a | 350.2%312.8% | 66.1%37.9% |
Long-Term Price Volatility Vs. Market
How volatile is Sisram Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Sisram Medical Ltd's (HKG:1696) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?1 month ago | Simply Wall St
Here's What To Make Of Sisram Medical's (HKG:1696) Returns On Capital2 months ago | Simply Wall St
Are Dividend Investors Making A Mistake With Sisram Medical Ltd (HKG:1696)?Valuation
Is Sisram Medical undervalued compared to its fair value and its price relative to the market?
21.5x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 1696 (HK$4.93) is trading above our estimate of fair value (HK$2)
Significantly Below Fair Value: 1696 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 1696 is good value based on its PE Ratio (21.5x) compared to the HK Medical Equipment industry average (30x).
PE vs Market: 1696 is poor value based on its PE Ratio (21.5x) compared to the Hong Kong market (11.9x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 1696's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 1696 is good value based on its PB Ratio (0.9x) compared to the HK Medical Equipment industry average (3.9x).
Next Steps
Future Growth
How is Sisram Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
35.5%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sisram Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine Sisram Medical's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Sisram Medical competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has Sisram Medical performed over the past 5 years?
21.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1696 has high quality earnings.
Growing Profit Margin: 1696's current net profit margins (8.2%) are lower than last year (14.7%).
Past Earnings Growth Analysis
Earnings Trend: 1696's earnings have grown significantly by 21.3% per year over the past 5 years.
Accelerating Growth: 1696's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 1696 had negative earnings growth (-45%) over the past year, making it difficult to compare to the Medical Equipment industry average (17.7%).
Return on Equity
High ROE: 1696's Return on Equity (4.2%) is considered low.
Next Steps
Financial Health
How is Sisram Medical's financial position?
Financial Position Analysis
Short Term Liabilities: 1696's short term assets ($191.4M) exceed its short term liabilities ($44.5M).
Long Term Liabilities: 1696's short term assets ($191.4M) exceed its long term liabilities ($18.1M).
Debt to Equity History and Analysis
Debt Level: 1696's debt to equity ratio (0.3%) is considered satisfactory.
Reducing Debt: 1696's debt to equity ratio has reduced from 686.1% to 0.3% over the past 5 years.
Debt Coverage: 1696's debt is well covered by operating cash flow (1110.2%).
Interest Coverage: 1696 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is Sisram Medical current dividend yield, its reliability and sustainability?
2.23%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 1696's dividend (2.23%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.08%).
High Dividend: 1696's dividend (2.23%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.55%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, 1696 has been paying a dividend for less than 10 years.
Growing Dividend: 1696's dividend payments have increased, but the company has only paid a dividend for 2 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (47.3%), 1696's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.8yrs
Average management tenure
CEO
Lior Dayan (50 yo)
3.58yrs
Tenure
US$759,000
Compensation
Mr. Lior Moshe Dayan has been Chief Executive Officer and Executive Director at Sisram Medical Ltd since June 6, 2017 and is responsible for its overall and day-to-day management and development. Mr. Dayan...
CEO Compensation Analysis
Compensation vs Market: Lior's total compensation ($USD759.00K) is above average for companies of similar size in the Hong Kong market ($USD304.46K).
Compensation vs Earnings: Lior's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.58yrs | US$759.00k | 0.026% $ 559.6k | |
| Executive Chairman | 4.75yrs | no data | no data | |
| CFO & Executive Director | 2yrs | no data | no data | |
| Chief Operating Officer | 2.75yrs | no data | no data | |
| Chief Strategy Officer | 2.83yrs | no data | no data | |
| Company Secretary | 1.08yrs | no data | no data |
2.8yrs
Average Tenure
51yo
Average Age
Experienced Management: 1696's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 3.58yrs | US$759.00k | 0.026% $ 559.6k | |
| Executive Chairman | 4.75yrs | no data | no data | |
| CFO & Executive Director | 2yrs | no data | no data | |
| Independent Non-Executive Director | 3.42yrs | US$25.00k | no data | |
| Non-Executive Director | 4.25yrs | no data | no data | |
| Non-Executive Director | 4.75yrs | no data | no data | |
| Independent Non-Executive Director | 3.42yrs | US$25.00k | no data | |
| Independent Non-Executive Director | 3.42yrs | US$25.00k | no data | |
| Independent Non-Executive Director | 3.42yrs | US$25.00k | no data | |
| Non-Executive Director | 1.42yrs | no data | no data | |
| Non-Executive Director | 0.42yr | no data | no data |
3.4yrs
Average Tenure
44yo
Average Age
Experienced Board: 1696's board of directors are considered experienced (3.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Sisram Medical Ltd's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Sisram Medical Ltd
- Ticker: 1696
- Exchange: SEHK
- Founded: 2003
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: HK$2.180b
- Shares outstanding: 442.16m
- Website: https://www.sisram-medical.com
Number of Employees
Location
- Sisram Medical Ltd
- 14 Halamish Street
- Caesarea Industrial Park
- Caesarea
- 38900
- Israel
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 1696 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Sep 2017 |
Biography
Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical and minimally invasive treatment systems in the Asia Pacific, Europe, North Amer...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/24 10:21 |
| End of Day Share Price | 2021/01/22 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.